BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21907823)

  • 21. Compartmentalization of growth factor receptor signalling.
    Hoeller D; Volarevic S; Dikic I
    Curr Opin Cell Biol; 2005 Apr; 17(2):107-11. PubMed ID: 15780584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel six-transmembrane protein hhole functions as a suppressor in MAPK signaling pathways.
    Zhou J; Li Y; Liang P; Yuan W; Ye X; Zhu C; Cheng Y; Wang Y; Li G; Wu X; Liu M
    Biochem Biophys Res Commun; 2005 Jul; 333(2):344-52. PubMed ID: 15950185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recycling and EH domain proteins at the synapse.
    Montesinos ML; Castellano-Muñoz M; García-Junco-Clemente P; Fernández-Chacón R
    Brain Res Brain Res Rev; 2005 Sep; 49(2):416-28. PubMed ID: 16054223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen peroxide reversibly inhibits epidermal growth factor (EGF) receptor internalization and coincident ubiquitination of the EGF receptor and Eps15.
    De Wit R; Makkinje M; Boonstra J; Verkleij AJ; Post JA
    FASEB J; 2001 Feb; 15(2):306-8. PubMed ID: 11156945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique intracellular trafficking processes associated with neural cell adhesion molecule and its intracellular signaling.
    Chen Y; Tang BL
    Cell Commun Adhes; 2010 Aug; 17(4-6):69-74. PubMed ID: 21244325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway.
    Goodger ZV; Rajendran L; Trutzel A; Kohli BM; Nitsch RM; Konietzko U
    J Cell Sci; 2009 Oct; 122(Pt 20):3703-14. PubMed ID: 19773363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vps9 domain-containing proteins: activators of Rab5 GTPases from yeast to neurons.
    Carney DS; Davies BA; Horazdovsky BF
    Trends Cell Biol; 2006 Jan; 16(1):27-35. PubMed ID: 16330212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emergence of intracellular metabolite signaling networks.
    Xu W; Zhao J; Zhao S
    IUBMB Life; 2016 Nov; 68(11):871-872. PubMed ID: 27766754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling gateway molecule pages--a data model perspective.
    Dinasarapu AR; Saunders B; Ozerlat I; Azam K; Subramaniam S
    Bioinformatics; 2011 Jun; 27(12):1736-8. PubMed ID: 21505029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated metabolism: a relevant player in prostate cancer progression and clinical management.
    Ferro M; Buonerba C; Di Lorenzo G; de Cobelli O; Terracciano D
    Transl Androl Urol; 2019 Mar; 8(Suppl 1):S109-S111. PubMed ID: 31143683
    [No Abstract]   [Full Text] [Related]  

  • 31. Liver X receptor agonists exert antitumor effects against hepatocellular carcinoma via inducing REPS2 expression.
    He XY; Zhu MM; Zheng J; Wang CY; Zhao XK; Zhang BT; Zhou DC; Zhang S; Yang XX; Duan YJ; Han JH; Chen YL
    Acta Pharmacol Sin; 2023 Mar; 44(3):635-646. PubMed ID: 35995867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.
    Li F; Ji JP; Xu Y; Liu RL
    Clin Transl Oncol; 2019 Aug; 21(8):1067-1075. PubMed ID: 30637711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
    Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
    Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.
    Rodriguez-Rocha H; Garcia Garcia A; Zavala-Flores L; Li S; Madayiputhiya N; Franco R
    Antioxid Redox Signal; 2012 Dec; 17(12):1676-93. PubMed ID: 22816731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reps2: a cellular signaling and molecular trafficking nexus.
    Badway JA; Baleja JD
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1660-3. PubMed ID: 21907823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.
    Oosterhoff JK; Penninkhof F; Brinkmann AO; Anton Grootegoed J; Blok LJ
    Oncogene; 2003 May; 22(19):2920-5. PubMed ID: 12771942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors.
    Nakashima S; Morinaka K; Koyama S; Ikeda M; Kishida M; Okawa K; Iwamatsu A; Kishida S; Kikuchi A
    EMBO J; 1999 Jul; 18(13):3629-42. PubMed ID: 10393179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?
    Naslavsky N; Caplan S
    J Cell Sci; 2005 Sep; 118(Pt 18):4093-101. PubMed ID: 16155252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A.
    Pandey KN
    Peptides; 2005 Jun; 26(6):985-1000. PubMed ID: 15911067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.